Table 3.

Independent t-tests between EQ-5D-5L and studied variables.

Parameters	Number of patients n (%)	EQ-5D-5L				P value
		Mean	Median	Standard deviation	Range
Sex						0.183
Female	74 (87.1)	0.8008	0.8406	0.1595	0.1722–0.9384
Male	11 (12.9)	0.8686	0.9384	0.1303	0.5960–0.9384
RA-related operations						0.055
Absence	45 (52.9)	0.8403	0.8973	0.1205	0.4168–0.9384
Presence	40 (47.1)	0.7750	0.8365	0.1854	0.1722–0.9384
Use of MTX						0.175
Absence	30 (35.3)	0.7782	0.8324	0.1666	0.2466–0.9384
Presence	55 (64.7)	0.8267	0.8973	0.1503	0.1722–0.9384
Use of bDMARDs						0.261
Absence	46 (54.1)	0.8305	0.8406	0.1267	0.4168–0.9384
Presence	39 (45.9)	0.7919	0.8555	0.1782	0.1722–0.9384
Use of oral steroids						0.032
Absence	76 (89.4)	0.8299	0.8893	0.1358	0.1722–0.9384
Presence	9 (10.6)	0.6383	0.7026	0.2213	0.2466–0.9384
Use of oral analgesics						0.001
Absence	60 (70.6)	0.8456	0.8973	0.1235	0.4168–0.9384
Presence	25 (29.4)	0.7233	0.7752	0.1944	0.1722–0.9384

EQ-5D-5L: the European Quality of Life questionnaire, five dimensions, five levels, RA: rheumatoid arthritis, MTX: methotrexate, bDMARDs: biological disease-modifying antirheumatic drugs.